Abstract
The objective of the present study was to investigate the physical stability of spray-dried proteins within surfactant-free hydrofluoroalkane (HFA) pressurised metered dose inhalers (pMDIs) during prolonged storage. Two model proteins (lysozyme and catalase) were spray-dried and stabilised in the presence of excipients, and subsequently suspended within HFA 134a. The pMDIs were stored valve-up for 6 months at room temperature (ca. 25 degrees C). Activities of the proteins were determined using biological assays and the fine particle fraction of the pMDIs was measured using a twin-stage impinger. The biological activities of catalase and lysozyme were found to be preserved in the presence of sugars and/or 80% hydrolysed polyvinyl alcohol (PVA) during spray drying. In addition, suspending the stabilised proteins within HFA for up to 6 months had little effect on their activity. The aerosolisation performance of lysozyme or catalase formulations containing either sucrose or trehalose as stabilisers appeared to deteriorate as a function of storage time. However, those formulations containing PVA were found to generate the greatest fine particle fraction, which in some cases was up to 50%, and to possess excellent physical stability during storage. The results indicated that the presence of PVA in the spray-dried stabilised protein particles could enhance the physical stability of particles, when suspended in the surfactant-free HFA MDI formulations, without affecting the protein stability upon prolonged storage. (c) 2005 Elsevier B.V All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 29-39 |
Number of pages | 11 |
Journal | International Journal of Pharmaceutics |
Volume | 304 |
Issue number | 1-2 |
DOIs | |
Publication status | Published - 4 Nov 2005 |
Keywords
- spray-drying
- protein stability
- metered dose inhaler
- pulmonary delivery
- catalase
- polyvinyl alcohol
- lysozyme
- hydrofluoroalkane
- THERAPEUTIC PROTEINS
- PRESERVATION
- FORMULATION
- SUSPENSION
- LYSOZYME
- LUNG